Argyro Syngelaki

Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia

Daniel L. Rolnik, D. Wright, Liona C. Poon et al. · New England Journal of Medicine · 2017 · 2.2K citations · Full text

Medicine, Obstetrics, Pharmacotherapy +17

Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population

K. H. Nicolaides, Argyro Syngelaki, Ghalia Ashoor et al. · American Journal of Obstetrics and Gynecology · 2012 · 627 citations

Medicine, Genetics, Obstetrics +17

Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation

N. O’Gorman, D. Wright, Argyro Syngelaki et al. · American Journal of Obstetrics and Gynecology · 2015 · 626 citations

Medicine, Maternal Health, Obstetrics +16

Competing Risks Model in Early Screening for Preeclampsia by Biophysical and Biochemical Markers

Ranjit Akolekar, Argyro Syngelaki, D. Wright et al. · Fetal Diagnosis and Therapy · 2012 · 601 citations · Full text

Medicine, Maternal Health, Obstetrics +17

ASPRE trial: performance of screening for preterm pre‐eclampsia

Daniel L. Rolnik, D. Wright, Liona C. Poon et al. · Ultrasound in Obstetrics and Gynecology · 2017 · 459 citations · Full text

Medicine, Maternal Health, Obstetrics +17